Slug
idweek2024
Global footer

PSE-US-2988 August 2024

CSS
.category-trials-slide--mmrv .trial-card__disease {
font-size: .8125rem;
letter-spacing: -.02em;
}

.trial-card--nct06059846 .trial-card__title,
.trial-card--nct05630846 .trial-card__title,
.trial-card--nct05298254 .trial-card__title,
.trial-card--nct06537414 .trial-card__title {
font-size: 1.125rem;
line-height: 1.375rem;
}

.trial-card--nct06389487 .trial-card__title {
font-size: 1.125rem;
line-height: 1.25rem;
}

.trial-card--nct05276297 .trial-card__title {
font-size: 1rem;
line-height: 1.25rem;
}

.trial-card--nct05921903 .trial-card__title {
font-size: 1rem;
line-height: 1.125rem;
}

.dialog-trial--nct03866187 .dialog-trial__title {
font-size: 2.2rem;
line-height: 2.9rem;
}

.dialog-trial--nct05276297 .dialog-trial__title {
font-size: 2.4rem;
line-height: 3.2rem;
}

._dialog-pipeline .list__item:first-child h3 {
font-size: 0;
line-height: 0;
}

._dialog-pipeline .list__item:first-child h3::after {
display: block;
content: "Anti-Infective Medicines";
font-size: 3.125rem;
line-height: 4rem;
color: var(--primary-400);
}
Global disclaimer

This document contains information for healthcare providers and is intended solely for educational purposes. This display includes ongoing clinical trials for both approved and investigational compounds. Some agents are approved for select indications. Inclusion in this display does not imply regulatory approval for these compounds or all indications. Information about all trials can be found at www.clinicaltrials.gov. All clinical study information updated as of October 9, 2024.